Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

B COMPLEX W C FORTE CAP 15 MG

VITAMIN B2 : 15 MG PYRIDOXINE HYDROCHLORIDE : 5 MG THIAMINE MONONITRATE : 35 MG CALCIUM D-PANTOTHENATE : 20 MG VITAMIN B12 : 10 MCG NICOTINAMIDE : 50 MG ASCORBIC ACID : 300 MG · DIN 00515965 · EVEREST PHARMACEUTICALS LTD.

Health Canada status: CANCELLED POST MARKET

What is B COMPLEX W C FORTE CAP?

B COMPLEX W C FORTE CAP 15 MG contains VITAMIN B2 : 15 MG PYRIDOXINE HYDROCHLORIDE : 5 MG THIAMINE MONONITRATE : 35 MG CALCIUM D-PANTOTHENATE : 20 MG VITAMIN B12 : 10 MCG NICOTINAMIDE : 50 MG ASCORBIC ACID : 300 MG. It is listed in the Health Canada Drug Product Database under DIN 00515965, held by EVEREST PHARMACEUTICALS LTD., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 14-Jul-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00515965
Brand nameB COMPLEX W C FORTE CAP
Generic / active ingredientVITAMIN B2 : 15 MG PYRIDOXINE HYDROCHLORIDE : 5 MG THIAMINE MONONITRATE : 35 MG CALCIUM D-PANTOTHENATE : 20 MG VITAMIN B12 : 10 MCG NICOTINAMIDE : 50 MG ASCORBIC ACID : 300 MG
ManufacturerEVEREST PHARMACEUTICALS LTD.
Strength15 MG
Dosage formCAPSULE
Route of administrationORAL
ScheduleNON-PRESCRIPTION DRUGS
ATC codeA11EB VITAMIN B-COMPLEX WITH VITAMIN C
AHFS class88:12.00 ; 88:08.00
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date14-Jul-1999
Original market date1980-12-31 00:00:00

Is VITAMIN B-COMPLEX WITH VITAMIN C in shortage in Canada?

A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for B COMPLEX W C FORTE CAP

What can be used instead?

Other Canadian products sharing ATC code A11EB VITAMIN B-COMPLEX WITH VITAMIN C. 0 of 70 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ALLBEE WITH C 550 CAP50 MGCAPSULEWHITEHALL-ROBINS INC.CANCELLED POST MARKETDIN 01932470
ALLBEE WITH VITAMIN C CAP10 MGCAPSULEWHITEHALL-ROBINS INC.CANCELLED POST MARKETDIN 01932489
B C ANTISTRESS CAP5 MGCAPSULELES LABORATOIRES BIO-SANTÉ INC.CANCELLED POST MARKETDIN 00479039
B COMPLEX 500 TAB10 MGTABLETNOBEL PHARM ENR.CANCELLED POST MARKETDIN 00510424
B COMPLEX PLUS C 300MG TAB10 MCGTABLETNUTRICORP INTERNATIONALCANCELLED POST MARKETDIN 02022311
B COMPLEX W VITAMIN C FORTIS CAP5 MGCAPSULESHOPPERS DRUG MART INC.CANCELLED POST MARKETDIN 00414832
B COMPLEX WITH C 300MG300 MGCAPSULEVITA HEALTH PRODUCTS INCCANCELLED POST MARKETDIN 00557390
B COMPLEX WITH C 300MG TAB15 MGTABLETPHARMAVITE LLCCANCELLED POST MARKETDIN 00723045
B COMPLEX WITH C 550MG10 MGCAPSULEVITA HEALTH PRODUCTS INCCANCELLED POST MARKETDIN 00557404
B PLUS C 300MG TIMED RELEASE15 MGTABLET (EXTENDED-RELEASE)VITA HEALTH PRODUCTS INCCANCELLED POST MARKETDIN 00537462

Who else supplies VITAMIN B-COMPLEX WITH VITAMIN C worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. VITAMIN B-COMPLEX WITH VITAMIN C appears in 130 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for B COMPLEX W C FORTE CAP

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for B COMPLEX W C FORTE CAP

Health Canada Drug Product Database (DPD), DIN 00515965. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.